| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | NIPAL4 ABCA3 CACNA2D2 ABCA12 SLC38A4 SLC35F1 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC7A4 CLCN1 SLC22A13 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 4.27e-08 | 1180 | 114 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC38A4 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 SLC17A7 CACNA1I ATP12A ATP4A | 5.15e-08 | 171 | 114 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | NIPAL4 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 6.49e-08 | 465 | 114 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.55e-07 | 105 | 114 | 8 | GO:0015171 | |
| GeneOntologyMolecularFunction | transporter activity | NIPAL4 ABCA3 CACNA2D2 ABCA12 SLC38A4 SLC35F1 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC7A4 CLCN1 SLC22A13 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 2.21e-07 | 1289 | 114 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC38A4 SLC7A7 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC22A13 SLC10A6 SLC17A7 | 3.08e-07 | 207 | 114 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC38A4 SLC7A7 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC22A13 SLC10A6 SLC17A7 | 3.22e-07 | 208 | 114 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.31e-06 | 15 | 114 | 4 | GO:0140161 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.57e-06 | 35 | 114 | 5 | GO:0005343 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | NIPAL4 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 2.84e-06 | 627 | 114 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 3.58e-06 | 6 | 114 | 3 | GO:0005332 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 3.66e-06 | 19 | 114 | 4 | GO:0015355 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 4.55e-06 | 20 | 114 | 4 | GO:0015174 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | NIPAL4 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 5.68e-06 | 664 | 114 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | NIPAL4 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 CLCN1 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 6.37e-06 | 758 | 114 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.95e-06 | 81 | 114 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A4 SLC7A7 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC22A13 SLC10A6 SLC17A7 | 7.05e-06 | 293 | 114 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 8.21e-06 | 23 | 114 | 4 | GO:0005283 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | NIPAL4 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 CLCN1 SCN4A SLC10A6 NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A | 1.12e-05 | 793 | 114 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 1.48e-05 | 9 | 114 | 3 | GO:0015185 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA3 ABCA12 SLC38A4 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC10A6 SLC17A7 ATP12A ATP4A | 1.83e-05 | 477 | 114 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.14e-05 | 29 | 114 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 4.97e-05 | 13 | 114 | 3 | GO:0061459 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.23e-05 | 119 | 114 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | P-type potassium:proton transporter activity | 9.66e-05 | 3 | 114 | 2 | GO:0008900 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.16e-04 | 17 | 114 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.64e-04 | 19 | 114 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.66e-04 | 90 | 114 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | symporter activity | 2.23e-04 | 150 | 114 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.95e-04 | 23 | 114 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC38A4 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC10A6 SLC17A7 | 3.00e-04 | 296 | 114 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 3.36e-04 | 301 | 114 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 4.28e-04 | 26 | 114 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | beta-N-acetylhexosaminidase activity | 4.77e-04 | 6 | 114 | 2 | GO:0004563 | |
| GeneOntologyMolecularFunction | collagen receptor activity | 4.77e-04 | 6 | 114 | 2 | GO:0038064 | |
| GeneOntologyMolecularFunction | ferrous iron transmembrane transporter activity | 4.77e-04 | 6 | 114 | 2 | GO:0015093 | |
| GeneOntologyMolecularFunction | ADP phosphatase activity | 6.66e-04 | 7 | 114 | 2 | GO:0043262 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 7.29e-04 | 71 | 114 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.56e-04 | 125 | 114 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 9.42e-04 | 76 | 114 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.13e-03 | 9 | 114 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.31e-03 | 83 | 114 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.41e-03 | 10 | 114 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type proton-exporting transporter activity | 1.41e-03 | 10 | 114 | 2 | GO:0008553 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.41e-03 | 10 | 114 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.42e-03 | 144 | 114 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 1.72e-03 | 11 | 114 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | iron ion transmembrane transporter activity | 1.72e-03 | 11 | 114 | 2 | GO:0005381 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.75e-03 | 151 | 114 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.05e-03 | 12 | 114 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.89e-03 | 103 | 114 | 4 | GO:0004553 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.01e-03 | 171 | 114 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.54e-03 | 109 | 114 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 4.15e-03 | 17 | 114 | 2 | GO:0015929 | |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 4.66e-03 | 18 | 114 | 2 | GO:0086080 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 4.66e-03 | 18 | 114 | 2 | GO:0015095 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 5.13e-03 | 61 | 114 | 3 | GO:0098632 | |
| GeneOntologyMolecularFunction | endopeptidase activator activity | 5.19e-03 | 19 | 114 | 2 | GO:0061133 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 5.74e-03 | 20 | 114 | 2 | GO:0017110 | |
| GeneOntologyBiologicalProcess | sodium ion transport | DRD2 SLC38A4 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 PKP2 SLC17A7 CACNA1I ATP12A ATP4A | 7.29e-08 | 275 | 120 | 12 | GO:0006814 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC38A4 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC17A7 CACNA1I ATP12A ATP4A | 3.61e-06 | 208 | 120 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC22A7 SLC6A1 SLC6A8 SLC6A11 PLLP CLCN1 SCN4A SLC10A6 NIPAL2 PKP2 SLC17A7 CACNA1I MMP9 ATP12A SLC25A28 ATP4A CYBA | 3.76e-06 | 1374 | 120 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 3.95e-06 | 19 | 120 | 4 | GO:1990822 | |
| GeneOntologyBiologicalProcess | metal ion transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 NIPAL2 PKP2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A CYBA | 5.02e-06 | 1000 | 120 | 19 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 PLLP CLCN1 SCN4A NIPAL2 SLC17A7 CACNA1I MMP9 ATP12A SLC25A28 ATP4A CYBA | 6.48e-06 | 1115 | 120 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | basic amino acid transport | 7.35e-06 | 22 | 120 | 4 | GO:0015802 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A NIPAL2 SLC17A7 CACNA1I MMP9 ATP12A SLC25A28 ATP4A CYBA | 8.49e-06 | 942 | 120 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A SLC10A6 NIPAL2 PKP2 SLC17A7 CACNA1I MMP9 ATP12A SLC25A28 ATP4A CYBA | 1.12e-05 | 1157 | 120 | 20 | GO:0006812 |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 1.43e-05 | 90 | 120 | 6 | GO:0140962 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.88e-05 | 195 | 120 | 8 | GO:0006865 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 CLCN1 SCN4A NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A CYBA | 2.37e-05 | 1017 | 120 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | NIPAL4 HIF1A DRD2 CACNA2D2 SLC38A4 SLC40A1 SLC6A1 SLC6A8 SLC6A11 SCN4A NIPAL2 SLC17A7 CACNA1I ATP12A SLC25A28 ATP4A CYBA | 2.45e-05 | 922 | 120 | 17 | GO:0098662 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | DRD2 SLC38A4 SLC7A7 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC22A13 SLC10A6 SLC17A7 | 2.79e-05 | 410 | 120 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | DRD2 SLC38A4 SLC7A7 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC22A13 SLC10A6 SLC17A7 | 2.92e-05 | 412 | 120 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CLDN18 SDK2 ITCH ABCA12 NT5E CDHR3 ITGA2 TENM2 CNTN6 CELSR1 ENTPD1 IZUMO1 PKP2 ALCAM SIGLEC1 SDK1 NCK2 CD276 | 5.02e-05 | 1077 | 120 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 7.28e-05 | 120 | 120 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 8.30e-05 | 15 | 120 | 3 | GO:1903826 | |
| GeneOntologyBiologicalProcess | iron import into the mitochondrion | 2.00e-04 | 4 | 120 | 2 | GO:0048250 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid reuptake | 2.00e-04 | 4 | 120 | 2 | GO:0051936 | |
| GeneOntologyBiologicalProcess | organic anion transport | DRD2 SLC38A4 SLC7A7 SLC7A6 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC22A13 SLC10A6 SLC17A7 | 2.12e-04 | 515 | 120 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 2.20e-04 | 51 | 120 | 4 | GO:0055078 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 2.30e-04 | 148 | 120 | 6 | GO:0032963 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 2.63e-04 | 442 | 120 | 10 | GO:0050878 | |
| GeneOntologyBiologicalProcess | surfactant homeostasis | 4.02e-04 | 25 | 120 | 3 | GO:0043129 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 4.39e-04 | 167 | 120 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | negative regulation of glomerular filtration | 4.96e-04 | 6 | 120 | 2 | GO:0003105 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.97e-04 | 313 | 120 | 8 | GO:0098742 | |
| GeneOntologyCellularComponent | potassium:proton exchanging ATPase complex | 9.44e-05 | 3 | 118 | 2 | GO:0005889 | |
| GeneOntologyCellularComponent | apical part of cell | LGMN DDR2 SLC22A7 SLC6A8 PTPRO SLC22A13 PTPRQ ADGRF5 C1QTNF5 ATP12A ATP4A CYBA | 1.32e-04 | 592 | 118 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | lamellar body membrane | 1.88e-04 | 4 | 118 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | apical plasma membrane | DDR2 SLC22A7 SLC6A8 PTPRO SLC22A13 PTPRQ C1QTNF5 ATP12A ATP4A CYBA | 4.43e-04 | 487 | 118 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | synaptic membrane | DRD2 CACNA2D2 PSENEN NT5E TENM2 CNTN6 SLC6A1 SLC6A8 SLC6A11 PTPRO ENTPD1 | 4.67e-04 | 583 | 118 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | presynapse | DRD2 KALRN CACNA2D2 PSENEN CDHR3 ITGA2 SLC35F1 SLC40A1 CNTN6 SLC6A1 SLC6A11 TNN ENTPD1 SLC17A7 | 4.75e-04 | 886 | 118 | 14 | GO:0098793 |
| GeneOntologyCellularComponent | plasma membrane protein complex | DRD2 CACNA2D2 PSENEN CDHR3 ITGA2 SSPOP TRBV7-4 SCN4A CACNA1I ALCAM ATP12A ATP4A CYBA | 4.93e-04 | 785 | 118 | 13 | GO:0098797 |
| Domain | BACK | 2.98e-05 | 60 | 112 | 5 | SM00875 | |
| Domain | BACK | 3.23e-05 | 61 | 112 | 5 | IPR011705 | |
| Domain | BACK | 3.23e-05 | 61 | 112 | 5 | PF07707 | |
| Domain | - | SDK2 KALRN NXPE1 PTGFRN CNTN6 TGM1 PTPRO TNN IZUMO1 ADGRF5 ALCAM SIGLEC1 SDK1 CD276 | 4.26e-05 | 663 | 112 | 14 | 2.60.40.10 |
| Domain | AA_permease_2 | 5.75e-05 | 13 | 112 | 3 | PF13520 | |
| Domain | AA/rel_permease1 | 5.75e-05 | 13 | 112 | 3 | IPR002293 | |
| Domain | Ig-like_fold | SDK2 KALRN NXPE1 PTGFRN CNTN6 TGM1 PTPRO TNN IZUMO1 ADGRF5 ALCAM SIGLEC1 SDK1 CD276 | 8.36e-05 | 706 | 112 | 14 | IPR013783 |
| Domain | IGc2 | 8.61e-05 | 235 | 112 | 8 | SM00408 | |
| Domain | Ig_sub2 | 8.61e-05 | 235 | 112 | 8 | IPR003598 | |
| Domain | Glyco_hydro_20_cat | 1.07e-04 | 3 | 112 | 2 | IPR015883 | |
| Domain | Glyco_hydro_20 | 1.07e-04 | 3 | 112 | 2 | PF00728 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.60e-04 | 18 | 112 | 3 | PS00754 | |
| Domain | SNF | 1.90e-04 | 19 | 112 | 3 | PF00209 | |
| Domain | Na/ntran_symport | 1.90e-04 | 19 | 112 | 3 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.90e-04 | 19 | 112 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.90e-04 | 19 | 112 | 3 | PS50267 | |
| Domain | IG | SDK2 KALRN PTGFRN CNTN6 IZUMO1 ADGRF5 ALCAM SIGLEC1 SDK1 CD276 | 2.23e-04 | 421 | 112 | 10 | SM00409 |
| Domain | Ig_sub | SDK2 KALRN PTGFRN CNTN6 IZUMO1 ADGRF5 ALCAM SIGLEC1 SDK1 CD276 | 2.23e-04 | 421 | 112 | 10 | IPR003599 |
| Domain | FA58C | 2.58e-04 | 21 | 112 | 3 | SM00231 | |
| Domain | FA58C_3 | 2.58e-04 | 21 | 112 | 3 | PS50022 | |
| Domain | FA58C_1 | 2.58e-04 | 21 | 112 | 3 | PS01285 | |
| Domain | FA58C_2 | 2.58e-04 | 21 | 112 | 3 | PS01286 | |
| Domain | Glycoside_hydrolase_SF | 2.86e-04 | 53 | 112 | 4 | IPR017853 | |
| Domain | AA-permease/SLC12A_dom | 2.97e-04 | 22 | 112 | 3 | IPR004841 | |
| Domain | AA_permease | 2.97e-04 | 22 | 112 | 3 | PF00324 | |
| Domain | F5_F8_type_C | 3.88e-04 | 24 | 112 | 3 | PF00754 | |
| Domain | FA58C | 3.88e-04 | 24 | 112 | 3 | IPR000421 | |
| Domain | Kelch | 4.05e-04 | 58 | 112 | 4 | SM00612 | |
| Domain | fn3 | 4.35e-04 | 162 | 112 | 6 | PF00041 | |
| Domain | Mg_trans_NIPA | 5.26e-04 | 6 | 112 | 2 | IPR008521 | |
| Domain | Mg_trans_NIPA | 5.26e-04 | 6 | 112 | 2 | PF05653 | |
| Domain | P-type_ATPase_IIC | 5.26e-04 | 6 | 112 | 2 | IPR005775 | |
| Domain | IG_LIKE | SDK2 KALRN PTGFRN CNTN6 IZUMO1 ADGRF5 ALCAM SIGLEC1 SDK1 CD276 | 7.43e-04 | 491 | 112 | 10 | PS50835 |
| Domain | Kelch_1 | 8.29e-04 | 70 | 112 | 4 | PF01344 | |
| Domain | Kelch_1 | 8.29e-04 | 70 | 112 | 4 | IPR006652 | |
| Domain | FN3 | 8.74e-04 | 185 | 112 | 6 | SM00060 | |
| Domain | Ig-like_dom | SDK2 KALRN PTGFRN CNTN6 IZUMO1 ADGRF5 ALCAM SIGLEC1 SDK1 CD276 | 8.93e-04 | 503 | 112 | 10 | IPR007110 |
| Domain | Neurexophilin | 9.75e-04 | 8 | 112 | 2 | PF06312 | |
| Domain | NXPH/NXPE | 9.75e-04 | 8 | 112 | 2 | IPR026845 | |
| Domain | GDA1_CD39_NTPase | 9.75e-04 | 8 | 112 | 2 | IPR000407 | |
| Domain | GDA1_CD39 | 9.75e-04 | 8 | 112 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 9.75e-04 | 8 | 112 | 2 | PS01238 | |
| Domain | Ig_I-set | 1.00e-03 | 190 | 112 | 6 | IPR013098 | |
| Domain | I-set | 1.00e-03 | 190 | 112 | 6 | PF07679 | |
| Domain | ig | 1.00e-03 | 190 | 112 | 6 | PF00047 | |
| Domain | Immunoglobulin | 1.00e-03 | 190 | 112 | 6 | IPR013151 | |
| Domain | BTB | 1.16e-03 | 131 | 112 | 5 | PF00651 | |
| Domain | - | 1.19e-03 | 35 | 112 | 3 | 3.20.20.80 | |
| Domain | FN3 | 1.27e-03 | 199 | 112 | 6 | PS50853 | |
| Domain | Glyco_hydro_catalytic_dom | 1.52e-03 | 38 | 112 | 3 | IPR013781 | |
| Domain | FN3_dom | 1.63e-03 | 209 | 112 | 6 | IPR003961 | |
| Domain | C2-set_2 | 1.90e-03 | 41 | 112 | 3 | PF08205 | |
| Domain | CD80_C2-set | 1.90e-03 | 41 | 112 | 3 | IPR013162 | |
| Domain | BTB-kelch_protein | 2.18e-03 | 43 | 112 | 3 | IPR017096 | |
| Domain | ABC_A | 2.26e-03 | 12 | 112 | 2 | IPR026082 | |
| Domain | Ldl_recept_a | 2.48e-03 | 45 | 112 | 3 | PF00057 | |
| Domain | BTB | 2.78e-03 | 160 | 112 | 5 | PS50097 | |
| Domain | LDLRA_1 | 2.98e-03 | 48 | 112 | 3 | PS01209 | |
| Domain | - | 2.98e-03 | 48 | 112 | 3 | 2.120.10.80 | |
| Domain | LDrepeatLR_classA_rpt | 3.16e-03 | 49 | 112 | 3 | IPR002172 | |
| Domain | LDLa | 3.16e-03 | 49 | 112 | 3 | SM00192 | |
| Domain | LDLRA_2 | 3.16e-03 | 49 | 112 | 3 | PS50068 | |
| Domain | - | 3.56e-03 | 15 | 112 | 2 | 3.30.70.960 | |
| Domain | Pept_M10A_Zn_BS | 3.56e-03 | 15 | 112 | 2 | IPR021158 | |
| Domain | ATPase_P-typ_TM_dom | 4.05e-03 | 16 | 112 | 2 | IPR023298 | |
| Domain | - | 4.05e-03 | 16 | 112 | 2 | 1.20.1110.10 | |
| Domain | Kelch-typ_b-propeller | 4.39e-03 | 55 | 112 | 3 | IPR015915 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.57e-03 | 17 | 112 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.57e-03 | 17 | 112 | 2 | PF00689 | |
| Domain | Hemopexin_CS | 4.57e-03 | 17 | 112 | 2 | IPR018486 | |
| Domain | BTB | 4.60e-03 | 180 | 112 | 5 | SM00225 | |
| Domain | Cation_ATPase_N | 5.12e-03 | 18 | 112 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 5.12e-03 | 18 | 112 | 2 | SM00831 | |
| Domain | BTB/POZ_dom | 5.16e-03 | 185 | 112 | 5 | IPR000210 | |
| Domain | Gal_Oxase/kelch_b-propeller | 5.35e-03 | 59 | 112 | 3 | IPR011043 | |
| Domain | SKP1/BTB/POZ | 5.64e-03 | 189 | 112 | 5 | IPR011333 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.70e-03 | 19 | 112 | 2 | IPR004014 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NIPAL4 ABCA3 ABCA12 SLC38A4 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A11 CLCN1 SLC10A6 NIPAL2 SLC17A7 LCN9 ATP12A ATP4A | 2.61e-06 | 681 | 95 | 17 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC38A4 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A11 SLC10A6 SLC17A7 LCN9 | 4.48e-06 | 238 | 95 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC38A4 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A11 SLC10A6 SLC17A7 LCN9 | 6.69e-06 | 249 | 95 | 10 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NIPAL4 ABCA3 ABCA12 SLC38A4 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A11 CLCN1 SLC10A6 NIPAL2 SLC17A7 LCN9 ATP12A ATP4A | 7.36e-06 | 736 | 95 | 17 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.58e-04 | 76 | 95 | 5 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.54e-04 | 84 | 95 | 5 | M27334 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 2.66e-04 | 19 | 95 | 3 | MM15523 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 2.66e-04 | 19 | 95 | 3 | M927 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 3.80e-04 | 51 | 95 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 3.80e-04 | 51 | 95 | 4 | MM14499 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 36048381 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 27899277 | ||
| Pubmed | 9.93e-06 | 212 | 121 | 7 | 19521566 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 20301593 | ||
| Pubmed | Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. | 1.20e-05 | 2 | 121 | 2 | 19211598 | |
| Pubmed | Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. | 1.20e-05 | 2 | 121 | 2 | 17548651 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32707842 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30056298 | ||
| Pubmed | Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases. | 1.20e-05 | 2 | 121 | 2 | 21164026 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22628316 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15756301 | ||
| Pubmed | A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians. | 1.20e-05 | 2 | 121 | 2 | 17998485 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23737488 | ||
| Pubmed | Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma. | 1.20e-05 | 2 | 121 | 2 | 23569336 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29103803 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 1.20e-05 | 2 | 121 | 2 | 15213259 | |
| Pubmed | CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression. | 1.20e-05 | 2 | 121 | 2 | 26226423 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29273916 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8247548 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 38275742 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18057185 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28389406 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27197253 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18838482 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15632415 | ||
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 1.20e-05 | 2 | 121 | 2 | 15703275 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28462381 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30150416 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28894087 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28666324 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33670307 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22421436 | ||
| Pubmed | CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells. | 1.20e-05 | 2 | 121 | 2 | 29066514 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28376099 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34741235 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31188623 | ||
| Pubmed | Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. | 1.20e-05 | 2 | 121 | 2 | 23771340 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15319286 | ||
| Pubmed | Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin. | 1.20e-05 | 2 | 121 | 2 | 34838540 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 38132171 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36720299 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24266925 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27423780 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11929769 | ||
| Pubmed | High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors. | 1.20e-05 | 2 | 121 | 2 | 24707115 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31705628 | ||
| Pubmed | A novel murine myotonia congenita without molecular defects in the ClC-1 and the SCN4A. | 1.20e-05 | 2 | 121 | 2 | 12370472 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25256099 | ||
| Pubmed | ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis. | 1.20e-05 | 2 | 121 | 2 | 37402102 | |
| Pubmed | Sequence CLCN1 and SCN4A genes in patients with nondystrophic myotonia in Chinese people. | 1.20e-05 | 2 | 121 | 2 | 35866763 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29243776 | ||
| Pubmed | Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39. | 1.20e-05 | 2 | 121 | 2 | 31652269 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32450615 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 38545102 | ||
| Pubmed | High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73. | 1.20e-05 | 2 | 121 | 2 | 31868071 | |
| Pubmed | Human platelets express functional ectonucleotidases that restrict platelet activation signaling. | 1.20e-05 | 2 | 121 | 2 | 32446352 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18337730 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23417379 | ||
| Pubmed | Benzamil-mediated urine alkalization is caused by the inhibition of H+-K+-ATPases. | 1.20e-05 | 2 | 121 | 2 | 33554781 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27906627 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24043462 | ||
| Pubmed | Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73). | 1.20e-05 | 2 | 121 | 2 | 37055675 | |
| Pubmed | Myotonia congenita: mutation spectrum of CLCN1 in Spanish patients. | 1.20e-05 | 2 | 121 | 2 | 31544778 | |
| Pubmed | Non-dystrophic myotonia Chilean cohort with predominance of the SCN4A Gly1306Glu variant. | 1.20e-05 | 2 | 121 | 2 | 32593548 | |
| Pubmed | Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. | 1.20e-05 | 2 | 121 | 2 | 27417582 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27061915 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32301730 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30409763 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19197536 | ||
| Pubmed | Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice. | 1.20e-05 | 2 | 121 | 2 | 18256308 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18328425 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21751260 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22514659 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 35246496 | ||
| Pubmed | Variability in CD39 and CD73 protein levels in uveal melanoma patients. | 1.20e-05 | 2 | 121 | 2 | 35199627 | |
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 1.20e-05 | 2 | 121 | 2 | 12230981 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31517732 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31974050 | ||
| Pubmed | Immunocytochemical localization of NTPDases1 and 2 in the neural retina of mouse and zebrafish. | 1.20e-05 | 2 | 121 | 2 | 19116950 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28432149 | ||
| Pubmed | The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy. | 1.20e-05 | 2 | 121 | 2 | 36776866 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28060378 | ||
| Pubmed | Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. | 1.20e-05 | 2 | 121 | 2 | 34265363 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27415035 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34650224 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26212582 | ||
| Pubmed | Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. | 1.20e-05 | 2 | 121 | 2 | 21677139 | |
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 1.20e-05 | 2 | 121 | 2 | 27644106 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.72e-05 | 91 | 121 | 5 | 28558017 | |
| Pubmed | 2.30e-05 | 162 | 121 | 6 | 25826454 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEXA KALRN MYO9B KHNYN AOC2 KDM3B MIB2 SLC6A8 CELSR1 ADAMTSL5 ENTPD2 CTSZ NCK2 CD276 | 3.17e-05 | 1105 | 121 | 14 | 35748872 |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 27431094 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22184407 | ||
| Pubmed | Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression. | 3.59e-05 | 3 | 121 | 2 | 28610954 | |
| Pubmed | Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients. | 3.59e-05 | 3 | 121 | 2 | 27044834 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 28236338 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 29370841 | ||
| Pubmed | A critical influence of HIF-1 on MMP-9 and Galectin-3 in oral lichen planus. | 3.59e-05 | 3 | 121 | 2 | 38951854 | |
| Pubmed | Role of HIF-1α-activated Epac1 on HSC-mediated neuroplasticity in stroke model. | 3.59e-05 | 3 | 121 | 2 | 23702312 | |
| Pubmed | Mutation spectrum and health status in skeletal muscle channelopathies in Japan. | 3.59e-05 | 3 | 121 | 2 | 32660787 | |
| GeneFamily | Solute carriers | SLC38A4 SLC35F1 SLC7A7 SLC7A6 SLC40A1 SLC22A7 SLC6A1 SLC6A8 SLC6A11 SLC7A4 SLC22A13 SLC10A6 SLC17A7 SLC25A28 | 8.99e-09 | 395 | 90 | 14 | 752 |
| GeneFamily | Fibronectin type III domain containing | 1.50e-05 | 160 | 90 | 7 | 555 | |
| GeneFamily | ATPase H+/K+ transporting | 7.33e-05 | 3 | 90 | 2 | 1211 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.53e-04 | 161 | 90 | 6 | 593 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.51e-04 | 134 | 90 | 5 | 861 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.03e-03 | 40 | 90 | 3 | 592 | |
| GeneFamily | Kelch like|BTB domain containing | 1.19e-03 | 42 | 90 | 3 | 617 | |
| GeneFamily | ATP binding cassette subfamily A | 2.14e-03 | 14 | 90 | 2 | 805 | |
| GeneFamily | Immunoglobulin like domain containing | 2.78e-03 | 193 | 90 | 5 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.51e-03 | 394 | 90 | 7 | 471 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.84e-03 | 21 | 90 | 2 | 813 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 6.30e-03 | 24 | 90 | 2 | 891 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.37e-03 | 26 | 90 | 2 | 253 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.93e-03 | 163 | 90 | 4 | 590 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 9.95e-03 | 89 | 90 | 3 | 353 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.59e-09 | 200 | 119 | 9 | 2cca77b2c9d829daa674a844e068f2b083e90d6e | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-08 | 162 | 119 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.73e-08 | 185 | 119 | 8 | 0e8064bb317f26959d3c59b4f73d0c455161ccd7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-08 | 199 | 119 | 8 | f965eb89d6d023c83154276b8fded490fd89c100 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 199 | 119 | 8 | 54a54ad983503ed515d476882d86b17d97892037 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.04e-07 | 155 | 119 | 7 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-07 | 162 | 119 | 7 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 2.99e-07 | 164 | 119 | 7 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-07 | 172 | 119 | 7 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.29e-07 | 173 | 119 | 7 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.29e-07 | 173 | 119 | 7 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-07 | 174 | 119 | 7 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-07 | 174 | 119 | 7 | 062e7bd9072ca7ee68e09b1da28af13f1bc60b44 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 181 | 119 | 7 | a93df1ba23d5b5f249491d69d12bfc0e274dafcf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-07 | 181 | 119 | 7 | 154d5e586cab25155c6d06dfe6ae01203b88e0fb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.24e-07 | 187 | 119 | 7 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-07 | 190 | 119 | 7 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.92e-07 | 196 | 119 | 7 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.03e-06 | 197 | 119 | 7 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 198 | 119 | 7 | eb0a94c426a7c567f94490b848e28784587c6dcd | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 198 | 119 | 7 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 198 | 119 | 7 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 199 | 119 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 199 | 119 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 199 | 119 | 7 | e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-06 | 199 | 119 | 7 | 994e885b8d1874006302a081d13f1ee881d64612 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 199 | 119 | 7 | ca0f6526ba0dcf8789dd3b583291519626427f2f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 199 | 119 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 119 | 7 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 119 | 7 | eac46978e2b3d38cf42b44f7b0350d0489d036b3 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 145 | 119 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.54e-06 | 153 | 119 | 6 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-06 | 157 | 119 | 6 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.42e-06 | 159 | 119 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.42e-06 | 159 | 119 | 6 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.10e-06 | 163 | 119 | 6 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.47e-06 | 165 | 119 | 6 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.47e-06 | 165 | 119 | 6 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 168 | 119 | 6 | eba865465feb0f42055bb8f98946050eeb03d177 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.07e-06 | 168 | 119 | 6 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 168 | 119 | 6 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 168 | 119 | 6 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 169 | 119 | 6 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 169 | 119 | 6 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-06 | 170 | 119 | 6 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.72e-06 | 171 | 119 | 6 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 6.72e-06 | 171 | 119 | 6 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.42e-06 | 174 | 119 | 6 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-06 | 174 | 119 | 6 | dc4298c1d9359f7e37454e9451f889017227d5cf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.18e-06 | 177 | 119 | 6 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-06 | 177 | 119 | 6 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-06 | 177 | 119 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-06 | 177 | 119 | 6 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.18e-06 | 177 | 119 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-06 | 178 | 119 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-06 | 178 | 119 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.45e-06 | 178 | 119 | 6 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.00e-06 | 180 | 119 | 6 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.59e-06 | 182 | 119 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 9.59e-06 | 182 | 119 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-06 | 182 | 119 | 6 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.89e-06 | 183 | 119 | 6 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 183 | 119 | 6 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 183 | 119 | 6 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-06 | 183 | 119 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 183 | 119 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 184 | 119 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 184 | 119 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 184 | 119 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 184 | 119 | 6 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 184 | 119 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 184 | 119 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 119 | 6 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 119 | 6 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 185 | 119 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 119 | 6 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 185 | 119 | 6 | 7460387f48f33674330bd53b759681b264228f5a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 186 | 119 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 186 | 119 | 6 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 186 | 119 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.08e-05 | 186 | 119 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 1.08e-05 | 186 | 119 | 6 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 187 | 119 | 6 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-05 | 187 | 119 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 187 | 119 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 1.15e-05 | 188 | 119 | 6 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 188 | 119 | 6 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 188 | 119 | 6 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-05 | 189 | 119 | 6 | 0a490730cdc912d5233de59057550de0e4065747 | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.22e-05 | 190 | 119 | 6 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 191 | 119 | 6 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.26e-05 | 191 | 119 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 191 | 119 | 6 | 629007189034ee8451411428f1c6cc57daee2d91 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-05 | 191 | 119 | 6 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 192 | 119 | 6 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.30e-05 | 192 | 119 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 192 | 119 | 6 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-05 | 192 | 119 | 6 | fb0d05a2c83816794652a6e5af8713e9bb22d5db | |
| Drug | BM212 | 4.33e-06 | 7 | 115 | 3 | CID000456926 | |
| Drug | chlorine cation | 4.33e-06 | 7 | 115 | 3 | CID006857643 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 8.16e-06 | 200 | 115 | 8 | 5570_UP | |
| Drug | mosapride | 8.47e-06 | 26 | 115 | 4 | CID000119583 | |
| Drug | BBCH | 9.91e-06 | 27 | 115 | 4 | CID000115288 | |
| Drug | AC1LA6XN | 1.03e-05 | 9 | 115 | 3 | CID000462826 | |
| Drug | 3-dimethylaminobenzoic acid | 1.47e-05 | 10 | 115 | 3 | CID000066837 | |
| Drug | lithium chromate | 1.98e-05 | 296 | 115 | 9 | CID000026627 | |
| Drug | gastrodin | 2.01e-05 | 11 | 115 | 3 | CID000115067 | |
| Drug | 3-nitro-4-hydroxyphenylacetic acid | 2.25e-05 | 112 | 115 | 6 | CID000447364 | |
| Drug | acetonitrile anion | 2.53e-05 | 2 | 115 | 2 | CID003015105 | |
| Drug | beta-homoproline | 2.53e-05 | 2 | 115 | 2 | CID000123784 | |
| Drug | M209-7 | 2.53e-05 | 2 | 115 | 2 | CID000079417 | |
| Drug | I Tax | 2.67e-05 | 12 | 115 | 3 | CID000003792 | |
| Drug | benzohydroxamic acid | 2.87e-05 | 35 | 115 | 4 | CID000010313 | |
| Drug | 1-Naphthylisothiocyanate | DPP7 LGMN HIF1A GALC IARS1 ACOX1 F5 SLC22A7 PTPRO NIPAL2 MMP9 MMP15 CTSZ CD276 CYBA | 3.31e-05 | 871 | 115 | 15 | ctd:D015058 |
| Drug | aldosterone | LGMN CACNA2D2 SLC7A6 SAR1A SCN4A CACNA1I C1QTNF5 MMP9 MMP15 CYBA | 3.40e-05 | 397 | 115 | 10 | CID000005839 |
| Drug | sipatrigine | 3.59e-05 | 37 | 115 | 4 | CID000060803 | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A | 4.52e-05 | 186 | 115 | 7 | 3391_DN | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 6041_UP | |
| Drug | 8-bromo-ATP | 6.70e-05 | 16 | 115 | 3 | CID003082217 | |
| Drug | (+/-)-verapamil hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 6.71e-05 | 198 | 115 | 7 | 161_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; PC3; HG-U133A | 6.93e-05 | 199 | 115 | 7 | 457_DN | |
| Drug | ASPAN | 7.56e-05 | 3 | 115 | 2 | CID005475577 | |
| Drug | AC1LUEYS | 7.56e-05 | 3 | 115 | 2 | CID001629204 | |
| Drug | Gaba-Glu | 7.56e-05 | 3 | 115 | 2 | CID000129795 | |
| Drug | 2,5-dimethyltetrahydrofuran | 7.56e-05 | 3 | 115 | 2 | CID000013855 | |
| Drug | glutathione monoester | 7.57e-05 | 86 | 115 | 5 | CID000452938 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 9.55e-06 | 11 | 116 | 3 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 9.55e-06 | 11 | 116 | 3 | cv:C0020758 | |
| Disease | Myotonia Congenita | 1.53e-05 | 2 | 116 | 2 | C0027127 | |
| Disease | Myotonia Levior | 1.53e-05 | 2 | 116 | 2 | C0270959 | |
| Disease | Becker Generalized Myotonia | 1.53e-05 | 2 | 116 | 2 | C0751360 | |
| Disease | Generalized Myotonia of Thomsen | 1.53e-05 | 2 | 116 | 2 | C2936781 | |
| Disease | eye colour measurement | 2.57e-05 | 218 | 116 | 7 | EFO_0009764 | |
| Disease | thrombosis (is_implicated_in) | 2.60e-05 | 15 | 116 | 3 | DOID:0060903 (is_implicated_in) | |
| Disease | Retinal Vein Occlusion | 4.58e-05 | 3 | 116 | 2 | C0035328 | |
| Disease | meningococcal meningitis (biomarker_via_orthology) | 4.58e-05 | 3 | 116 | 2 | DOID:0080176 (biomarker_via_orthology) | |
| Disease | Thrombosis of retinal vein | 4.58e-05 | 3 | 116 | 2 | C1527411 | |
| Disease | Hyperkalemic periodic paralysis | 4.58e-05 | 3 | 116 | 2 | C0238357 | |
| Disease | epilepsy (implicated_via_orthology) | 4.66e-05 | 163 | 116 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Ichthyosis Congenita I | 9.15e-05 | 4 | 116 | 2 | C4551630 | |
| Disease | Harlequin Fetus | 9.15e-05 | 4 | 116 | 2 | C0239849 | |
| Disease | Ichthyosis Congenita II | 9.15e-05 | 4 | 116 | 2 | C3536797 | |
| Disease | autosomal recessive congenital ichthyosis 1 (is_implicated_in) | 9.15e-05 | 4 | 116 | 2 | DOID:0060656 (is_implicated_in) | |
| Disease | Collodion Fetus | 9.15e-05 | 4 | 116 | 2 | C3543867 | |
| Disease | Congenital ichthyosis | 1.52e-04 | 5 | 116 | 2 | C0020758 | |
| Disease | cardiovascular measurement | 2.27e-04 | 6 | 116 | 2 | EFO_0004298 | |
| Disease | Myotonia | 2.27e-04 | 6 | 116 | 2 | C0027125 | |
| Disease | Liver Cirrhosis, Experimental | 2.44e-04 | 774 | 116 | 11 | C0023893 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 3.18e-04 | 7 | 116 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | atrial natriuretic factor measurement | 3.18e-04 | 7 | 116 | 2 | EFO_0004789 | |
| Disease | retinal vein occlusion (is_implicated_in) | 3.18e-04 | 7 | 116 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | retinal ischemia (biomarker_via_orthology) | 3.18e-04 | 7 | 116 | 2 | DOID:12510 (biomarker_via_orthology) | |
| Disease | brain ischemia (implicated_via_orthology) | 3.53e-04 | 35 | 116 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | myocardial infarction (is_implicated_in) | 6.40e-04 | 99 | 116 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | platelet component distribution width | KALRN MYO9B TMPRSS6 ITGA2 TNN ENTPD1 ADGRF5 SIGLEC1 CTSZ NCK2 | 8.09e-04 | 755 | 116 | 10 | EFO_0007984 |
| Disease | disease progression measurement, Crohn's disease | 8.46e-04 | 47 | 116 | 3 | EFO_0000384, EFO_0008336 | |
| Disease | iron biomarker measurement | 9.00e-04 | 48 | 116 | 3 | EFO_0004461 | |
| Disease | Hepatic fibrosis | 9.56e-04 | 49 | 116 | 3 | HP_0001395 | |
| Disease | nervous system disease (implicated_via_orthology) | 9.86e-04 | 12 | 116 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | skin melanoma (is_marker_for) | 1.16e-03 | 13 | 116 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Left ventricular noncompaction | 1.35e-03 | 14 | 116 | 2 | C1960469 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Withdrawal Symptoms | 1.56e-03 | 58 | 116 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.56e-03 | 58 | 116 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.56e-03 | 58 | 116 | 3 | C0038587 | |
| Disease | pre-eclampsia (is_marker_for) | 1.56e-03 | 58 | 116 | 3 | DOID:10591 (is_marker_for) | |
| Disease | Brain Ischemia | 1.72e-03 | 60 | 116 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 1.72e-03 | 60 | 116 | 3 | C0917798 | |
| Disease | Seizures | 1.74e-03 | 218 | 116 | 5 | C0036572 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 1.77e-03 | 16 | 116 | 2 | DOID:10964 (is_marker_for) | |
| Disease | calcium/calmodulin-dependent protein kinase type 1 measurement | 1.77e-03 | 16 | 116 | 2 | EFO_0008062 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.77e-03 | 16 | 116 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.77e-03 | 16 | 116 | 2 | C2713443 | |
| Disease | Adenomatous Polyposis Coli | 2.00e-03 | 17 | 116 | 2 | C0032580 | |
| Disease | iron biomarker measurement, ferritin measurement | 2.51e-03 | 19 | 116 | 2 | EFO_0004459, EFO_0004461 | |
| Disease | stroke | 2.55e-03 | 144 | 116 | 4 | EFO_0000712 | |
| Disease | iron biomarker measurement, transferrin measurement | 2.78e-03 | 20 | 116 | 2 | EFO_0004461, EFO_0006341 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.78e-03 | 20 | 116 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.06e-03 | 21 | 116 | 2 | C1800706 | |
| Disease | Alzheimer disease | 3.11e-03 | 485 | 116 | 7 | MONDO_0004975 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.48e-03 | 157 | 116 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | colorectal cancer (is_marker_for) | 3.48e-03 | 157 | 116 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Disproportionate short stature | 3.50e-03 | 77 | 116 | 3 | C0878659 | |
| Disease | total iron binding capacity | 3.63e-03 | 78 | 116 | 3 | EFO_0006334 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNWTDAEGYYRVNIG | 666 | Q13523 | |
| YGARQYDQGVDLWSV | 176 | Q8IZL9 | |
| PWNYQIDYFGVAATV | 981 | O43683 | |
| AIRNYTLWRVGDYGS | 181 | Q9UBR2 | |
| LWQVFGSATGVTRYY | 246 | Q9NY47 | |
| RQGWQRYYFEGIKQT | 316 | O95433 | |
| QYIARYEEQGIGLQW | 1221 | Q86UK0 | |
| YQENFYAWSAPGVGR | 1291 | Q99758 | |
| EQWRVQTGLELYEGY | 356 | P0C7M7 | |
| YTVTGAEQIQYRRGW | 251 | Q6MZZ7 | |
| YRGYPEAEVFWQDGQ | 386 | Q5ZPR3 | |
| TGSVRSQEDQWYLGY | 26 | Q8IYA2 | |
| GVSDGRWHSVQVQYY | 1521 | Q9NYQ6 | |
| ADAFYQRGYRWAGFI | 306 | O43246 | |
| GQERFWTITSSYYRG | 66 | Q92928 | |
| QSQQYLYWDGERRTY | 601 | P98175 | |
| VSAFFSYQAWRGVGS | 156 | Q9Y342 | |
| VRSVSSVGNYDYIWD | 456 | O75106 | |
| FFSGRQVWVYTGASV | 581 | P14780 | |
| AGREWYYGNVTRHQA | 281 | O43639 | |
| GINVGTYRIYWYQQK | 46 | A0A0G2JS06 | |
| GYIRIWGVNTYVTQV | 1751 | Q2M2H8 | |
| YVGWRNESATNGYIE | 256 | Q16832 | |
| RGGYVWVETQATVIY | 311 | Q16665 | |
| WTGYTAFFVGILVQQ | 931 | P54707 | |
| YWRFNEETQRGDPGY | 486 | P51511 | |
| RNYNVARVSGVWYSI | 26 | Q8WX39 | |
| IVATAGRFTQWYFGA | 26 | P13498 | |
| GRFTQWYFGAYSIVA | 31 | P13498 | |
| GVFGWVTANYLLENF | 166 | Q9Y5L3 | |
| ELFDYGLQQYWGSRA | 176 | A0A1W2PR82 | |
| SAFFASWRIVYEGGI | 501 | P11678 | |
| SGYTVEYREEGSQIW | 2601 | O60229 | |
| QGIILTGWQRYDHYS | 291 | Q8WVB3 | |
| WQNEGAGAFYRSYTT | 216 | Q96A46 | |
| RLYEEYGVQGWAIVQ | 1661 | Q7LBC6 | |
| AVFENKIYVVGGYSW | 541 | Q9P2J3 | |
| GQEEGAYGWITINYL | 171 | P49961 | |
| YFVNVTTRIWNGTFA | 1071 | P17301 | |
| VFRDAGAFAGYWNVT | 206 | Q6ZMM2 | |
| AYTEQSQIKGYVWRS | 46 | Q9NZ42 | |
| YEVAYQAEAGWFSQR | 236 | O75694 | |
| KYNVFTRVNISYWEG | 146 | Q16827 | |
| WYRFQVAASTNAGYG | 1551 | Q9UMZ3 | |
| GWEQRVDQHGRVYYV | 331 | Q96J02 | |
| LGRYDGNVYENLFEW | 621 | Q15067 | |
| ENKIYVVGGYSWNNR | 586 | Q9P2N7 | |
| WVQVGVGDYIGIYAS | 206 | Q9BXJ0 | |
| AFRVNWLSGTYFEVV | 71 | Q6ZTQ4 | |
| TRQVSSYYGGEQEDW | 956 | Q8TF40 | |
| LGLYFGEQAYLRSSW | 1226 | Q9P0X4 | |
| WVTNYIASVYVRGQE | 31 | Q6P9A2 | |
| NTGRVLGYEVLYWTD | 831 | Q9UQ52 | |
| NRGRAEVYYSGTWGT | 431 | Q9UEW3 | |
| YFSSRGIAIAVQYFW | 456 | O15037 | |
| EGLTDYSFYRVWGNN | 191 | Q8IYV9 | |
| YSFYRVWGNNTETLV | 196 | Q8IYV9 | |
| VLYSAFTWLGYVNSA | 406 | P14416 | |
| RSVQVIGGIWVTYEY | 1536 | Q9Y4K1 | |
| FFWIFANGSYRVTGD | 596 | P54803 | |
| VVVWFGVNFSYYGLS | 351 | Q9Y694 | |
| WFVDSLGYYGLSLQV | 341 | Q9Y226 | |
| IITGYQISWEVYGRN | 1001 | Q7Z5N4 | |
| IQGYKIYFWEAQRGN | 1656 | Q58EX2 | |
| LGWYTVNSAYGDTII | 26 | Q13740 | |
| YNTGWVLCQIGRAYF | 496 | P30260 | |
| QTRYTFGAALFVGWV | 166 | P56856 | |
| DSYGQEWTFGQRLYQ | 911 | P20648 | |
| FLQGAYDTVRWEFGT | 231 | Q9UHL4 | |
| YEYDIRGDQWINIGT | 586 | Q86V97 | |
| NGTYLVSFTLFWEGQ | 161 | Q8N323 | |
| WDQGTRTNYRAGYQG | 56 | Q96AX9 | |
| DIVSSYGKGYVVWQE | 361 | P06865 | |
| GISVGSYRIYWYQQK | 46 | A0A075B6I7 | |
| SGEANVRFTVSWYYR | 436 | Q9P2B2 | |
| ISWFYGVNRFYDNIQ | 471 | P30531 | |
| LAGYFYSQDPAQIWR | 466 | P51649 | |
| ALRQYYFTVGWNIFD | 1406 | P35499 | |
| YSFWGGQGCRYSLVQ | 581 | A2VEC9 | |
| LRQFYVAAQGISWSY | 31 | P12259 | |
| GINVGTYRIYWYQQK | 46 | A0A087WSX0 | |
| NNGTYLVSFTLFWEG | 171 | Q96DL1 | |
| YILSWYGNLSRDEGQ | 16 | Q9H3E2 | |
| NAVIYYRVGDNVWTE | 346 | Q9NVX7 | |
| QAISARTVQYYLVGW | 166 | Q9H841 | |
| VWNQRYFVISNTTGY | 236 | P49354 | |
| EWIYNGFSSVLQFLG | 6 | Q9NR31 | |
| RDGWVSYYNQPVFLA | 296 | Q9NP59 | |
| NKASGWSVQYRYDGV | 2291 | Q9NT68 | |
| EVNQLWAGLGYYSRG | 166 | Q9UIF7 | |
| GVLVQYSGWSSVFYV | 226 | Q9P2U7 | |
| FGNIVCYNWYGDGRI | 231 | Q8NEZ3 | |
| FIAEGIDQTRGWFYT | 556 | P41252 | |
| WIDAGTQIFFSYAIG | 306 | P48029 | |
| TGEWYLNGNYLIIFV | 191 | Q969I6 | |
| NLFRGAEYNRYTWVT | 141 | Q9NRC1 | |
| QYQGTIWFTVYKGAE | 86 | P21589 | |
| EVYWNTSAGIKIYQR | 501 | Q8IZF2 | |
| LVGYITNYSRRFWQG | 21 | Q8WUX2 | |
| EVTSTYFAVRNYWRG | 291 | P35523 | |
| GATLYGISNVWEEYI | 226 | Q5T1Q4 | |
| EARIFTFGTWIYSVN | 266 | P98170 | |
| AYKVYVWAERGNQGS | 506 | Q9UQP3 | |
| CDQVVWTGYYGLVYN | 426 | C9JQI7 | |
| LFGRVYTLSTAGQYW | 11 | Q7Z6L1 | |
| SFSYWFFVGLSIVGQ | 386 | Q9UM01 | |
| GFSTWTYRQGYDVSI | 216 | Q93063 | |
| CIGWVYGSNRFYDNI | 486 | P48066 | |
| VAFGVYVNYRWPKQS | 176 | Q3KNW5 | |
| VGFIYGYVAEQFGWT | 101 | Q9Y6A9 | |
| FNTGALYTQIGTWRY | 136 | A8MT19 | |
| TAIWYYDYSGQRQVV | 56 | Q9BZZ2 | |
| WQERIRQNYGFYIGL | 46 | Q0D2K0 | |
| SYWFFVGLSVVGQLY | 396 | Q92536 | |
| YYGTEAQIGERTWNY | 276 | P22735 | |
| FSVNSIIYRWQGYEG | 611 | Q8WU66 | |
| IIYRWQGYEGFVAVH | 616 | Q8WU66 | |
| GATYFQRGSLFWFTV | 6 | Q8TBM7 | |
| TATYEGRWGRGTAQY | 116 | Q99959 | |
| SGHVTLYWYRQTLGQ | 46 | A0A1B0GX95 | |
| FATVWGREQYTLYGI | 486 | O15321 | |
| NYFGVYTRITGVISW | 791 | Q8IU80 | |
| NGRIYLVGGYSIWTN | 546 | Q96NJ5 | |
| VVIVAGSNGWYNYRH | 31 | Q99538 | |
| RTQAAVYLQASWRGY | 1001 | Q13459 |